We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Report on the service providing sterile, controlled environments for the preparation of injectable medicines into ready-to-administer formats for patients.
Guidance for manufacturers on reporting adverse incidents involving breast implants under the vigilance system.
Guidance for hospital blood banks on issuing blood components electronically in line with best practice.
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.
Information on how the ACBS factors in the issue of pricing, when reviewing product applications.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
A summary of actions related to problems with T34 syringe drivers
Advice and guidance on the management and use of point-of-care testing (POCT) in vitro diagnostic (IVD) devices.
AI Airlock programme develops industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.
An overview of the five technologies selected for the AI Airlock pilot.
Information for patients, healthcare professionals and the wider public to help better understand the importance of AAIs as a potential life-saving medicine.
Guidance for local partnerships on how to review adult drug and alcohol related deaths and near-fatal overdoses to prevent future deaths.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.
A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
Helping interpret the Human Medicines (Amendment) Modular Manufacture and Point of Care regulations 2025 regulations.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
Information and advice on submitting a dermatological product to the Advisory Committee for Borderline Substances (ACBS).
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).